TradeTrade
Jump to any asset 849 assets, updated daily

As of September 15, 2026, Zions Bancorporation, National Association (ZION) trades at $68.52. CleaRank Financial AI rates it Hold with a fair value of $75.00, 9.5% above the current price. Wall Street's consensus target is $75.00 across 22 analysts. RSI at 55 is in neutral territory, and the price is below its 50-day average of $69.67.

Zions Bancorporation, National Association (ZION)

Zions Bancorporation, National Association NASDAQ

$68.52 -0.6650 (-0.96%)
Latest Price
AI Analyst Consensus
Hold
50 / 100
Zions Bancorporation, National Association (ZION) is trading at $68.515, positioned above its 200-day moving average but below its 50-day moving average, indicating a neutral short-term trend. The company's fundamentals show a strong return on equity of 16.40% and a profit margin of 31.76%, which are above sector medians. However, recent insider activity shows a net selling trend, with total sales exceeding purchases by a significant margin, signaling potential caution from management. Wall Street analysts are divided, with a 'Hold' consensus score of 50, reflecting 12 'Hold' ratings out of 22. The median analyst price target of $75.00 suggests a modest upside of 9.47% from the current price. While the company's earnings have shown positive surprises in recent quarters, the forward growth estimates for revenue and earnings are modest, suggesting a period of stabilization rather than aggressive expansion.

ZION Price Analysis

Market Metrics

Open
$69.53
Day Range
$68.49 to $69.73
Prev Close
$69.18
Volume
27.1K
52-Week Range
$46.19 to $73.34
Market Cap
$10.10B

Peer Benchmarking

Valuation vs Sector (Financial Services)

Performance vs KBE

Sector Position Analysis
Trading at a notable discount to sector peers (-47%), which may indicate undervaluation or specific company headwinds.

ZION Financial Performance

Revenue vs. Earnings

Annual

Quarterly

Earnings Reality Check

Analysis: In the last 5 quarters, ZION beat estimates 5 times. The stock rose 3 times the next day. Price tends to react positively to beats.

ZION Analysis

Company's Health 3/5
12-Month Analyst Target +9.47% Upside
Median of 22 analysts (12-month)
$75.00
AI Technical Analysis Hold
With an RSI of 55.42, Zions Bancorporation is exhibiting neutral momentum, neither overbought nor oversold. The stock is currently trading below its 50-day and 20-day exponential moving averages at $69.67 and $68.69 respectively, suggesting near-term downward pressure. However, it remains above its 200-day moving average at $62.89, which acts as a key support level. The MACD is slightly negative at -0.24, indicating a lack of strong bullish momentum. Volume has been significantly below average recently, suggesting a lack of conviction from traders. The current price action around the 50-day SMA indicates a critical juncture, where a break below could signal further downside towards the 200-day SMA, while holding above it could lead to a retest of recent highs.
ProTips
  • Monitor upcoming earnings reports closely, as recent beats have not consistently translated into positive price action.
  • The stock is trading below its 50-day moving average, suggesting caution for short-term traders until a clear upward trend is re-established.
  • Given the moderate insider selling, consider the overall market sentiment and sector performance before initiating new positions.
Key Catalysts
Bearish Moderate Insider Selling Signal

Insiders have sold $10.2 million worth of stock versus purchasing $265.6 thousand, indicating a moderate sell signal and potential lack of confidence from management.

Source: Insider Activity Data
Neutral Mixed Wall Street Analyst Ratings

With 12 'Hold' ratings, 2 'Sell', and 2 'Strong Sell' out of 22 analysts, the consensus is divided, potentially limiting significant upward price momentum.

Source: Wall Street Analyst Data
Bullish Strong Profitability Metrics

Zions Bancorporation's profit margin of 31.76% and return on equity of 16.40% significantly outperform sector averages, providing a fundamental floor.

Source: Company Fundamentals
Bullish Attractive Valuation

The P/E ratio of 8.81 and P/S ratio of 2.74 are well below sector medians, suggesting the stock may be undervalued relative to its peers.

Source: Company Fundamentals
Market Outlook
The base case for Zions Bancorporation over the next 6-12 months suggests a period of stabilization, with the stock likely trading within a range defined by its 50-day and 200-day moving averages. The median analyst target of $75.00 implies a modest upside, supported by its attractive valuation and strong profitability metrics relative to the sector. However, significant upside catalysts appear limited given the moderate insider selling and mixed Wall Street sentiment. A breach below the 200-day moving average at $62.89 would be a key downside risk, potentially signaling further deterioration. Conversely, a strong earnings beat coupled with positive forward guidance could shift sentiment and drive the stock towards its higher analyst targets.

Key Statistics

Market Cap 10.10B
P/E Ratio 8.81
EPS (TTM) 7.85
Dividend Yield 2.67%
52 Week High 73.34
52 Week Low 46.19
Zions Bancorporation trades at a P/E ratio of 8.81, significantly below the sector median of 16.50, and its price-to-sales ratio of 2.74 is also below the sector average of 3.80. This suggests a potentially attractive valuation relative to its peers. The company boasts a strong return on equity of 16.40% and a profit margin of 31.76%, both exceeding sector averages. Despite the favorable valuation and profitability metrics, the forward revenue growth estimates are modest, with current year growth projected at 6.00% and next year at 2.00%. This slower growth trajectory, coupled with a 'Hold' consensus from Wall Street, suggests that the market may be pricing in limited near-term catalysts for significant appreciation. The company's debt-to-equity ratio is 0.00, indicating a very strong balance sheet with no leverage.

Earnings & Growth Analysis

Zions Bancorporation has demonstrated a pattern of beating analyst EPS estimates in recent quarters, notably with a 58.85% surprise in the quarter to June 2026, reporting $3.05 against an estimate of $1.92. Despite these positive earnings surprises, the stock experienced a price decline of 3.95% following the most recent report. The company's earnings performance has been inconsistent in terms of price reaction, with some beats leading to gains and others to losses. The forward EPS estimates for the current year are $7.78, with a projected decrease to $6.82 next year, indicating a potential slowdown in earnings growth. Revenue growth is also expected to moderate, with current year growth at 6.00% and next year at 2.00%.

Key Risks

A primary risk for Zions Bancorporation is the moderate insider selling signal, with total sales significantly outweighing purchases, suggesting a lack of strong conviction from management. The stock's current position below its 50-day moving average also indicates potential near-term weakness and a risk of further decline towards the 200-day support level. Also, the mixed 'Hold' consensus from Wall Street analysts, with a notable number of 'Sell' and 'Underweight' ratings, presents a risk of downward pressure on the stock if sentiment shifts further. Modest forward growth estimates also temper the upside potential.

Technical Indicators i

RSI (14) 55.42
MACD -0.24
SMA 50 69.67
SMA 200 62.89
Technical Rating Neutral
RSI
Neutral
SMA Cross
Bullish
Price vs SMA
Bearish
MACD
Bearish
Golden Cross in effect with the 50-day SMA ($69.67) above the 200-day SMA ($62.89), price is trading below the 50-day SMA.

Market Correlations

How this stock moves relative to other assets

Based on 1 year of daily price data. Correlations may vary over different time periods.

S&P 500 (SPY) +0.57
Moderate correlation
Nasdaq 100 (QQQ) +0.45
Moderate correlation
Bitcoin (BTC) +0.12
Weak correlation
Gold (XAU) -0.06
Weak correlation
Check Custom Correlation

How does any other asset move with ZION? One year of daily closes, Pearson correlation.

Try

ZION Trade Plans

Specific entry, exit, and risk management levels

Select Your Trade Bias
Risk Tolerance
Conservative 2% Aggressive
Portfolio Value
$
Position Size: Enter portfolio size →

Entry Strategies pick an entry style

Conservative
$67.83
Slight discount to current
Wait for small dip
Aggressive
$68.52
At current price
Enter now if confident

Risk Management

STOP LOSS
$65.79
MAX LOSS
-3.0%
Volatility-Adjusted Stop Loss
Calculated based on RSI (55.4) and current market volatility

Profit Targets (Based on Conservative Entry)

TARGET 1
$69.86
+3% (Conservative)
+2.0% (Aggressive)
TARGET 2
$71.22
+5% (Conservative)
+3.9% (Aggressive)
TARGET 3
$73.26
+8% (Conservative)
+6.9% (Aggressive)
Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3
Disclaimer
This AI-generated trade plan for ZION is for educational and informational purposes only and does not constitute financial advice. The analysis is based on historical data patterns and technical indicators which may not predict future results. Stock trading involves risk of loss. Verify all data independently and consult a qualified financial advisor. Generated on September 15, 2026.

Growth of $10,000

A $10,000 investment in ZION in September 2016 would be worth about $22,794 today, compared with about $35,344 for the same investment in the S&P 500 benchmark.

Compare with Another Ticker

Monte Carlo Projection (10yr)

CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in ZION today could grow to about $21,417 by 2036 in the base case, with a bull case near $105,860 and a bear case around $4,333. Projections are statistical simulations, not guarantees.

ZION Stock Price Prediction: 2030

CleaRank's simulation projects a price near $92.91 for ZION by 2030 in the base case, from $68.52 today (1.4x over 4 years). The downside path ends near $33.82. These are outcomes of a Monte Carlo simulation run on ZION's historical return distribution, not price targets, and they assume no dividends are reinvested.

ZION simulated price paths by year
Year Downside (10th pct) Base case Upside (90th pct)
2027 $44.61 $73.94 $123
2028 $39.05 $79.79 $163
2029 $35.88 $86.10 $207
2030 $33.82 $92.91 $255
2031 $32.39 $100 $310
2032 $31.38 $108 $373
2033 $30.67 $117 $445
2034 $30.18 $126 $526
2035 $29.86 $136 $619
2036 $29.69 $147 $725

Method: 10,000 simulated price paths using ZION's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice.

People Also Watch

ZION Insider Trading Analysis

Source: SEC Form 4
Bought
$265.6K
1 Transactions
Sold
$10.2M
15 Transactions
Insiders
15
Active Traders
$ Avg Transaction
$656.6K
Moderate size
Recent insider transactions in ZION
Date Insider Type Shares Value
Jul 26, 2024
MCLEAN SCOTT J
President
Sell 120.0K $6.2M
Aug 4, 2026
MCLEAN SCOTT J
President
Sell 83.3K $5.9M
Feb 9, 2021
SIMMONS HARRIS H
Chief Executive Officer
Sell 60.5K $3.0M
Feb 14, 2022
ANDERSON ALDON SCOTT
Officer
Sell 30.7K $2.2M
Feb 10, 2021
MCLEAN SCOTT J
President
Sell 40.0K $2.0M
Feb 2, 2026
MCLEAN SCOTT J
President
Sell 29.0K $1.8M
Feb 24, 2021
BURDISS PAUL E
Chief Financial Officer
Sell 30.5K $1.7M
Jan 28, 2021
SCHREIBER EDWARD P
Officer
Sell 35.3K $1.6M
Feb 18, 2025
SMITH JENNIFER ANNE
Officer
Sell 22.7K $1.3M
Feb 3, 2022
ROBINSON REBECCA K
Officer
Sell 15.1K $1.1M

Frequently Asked Questions

What is Zions Bancorporation's stock price forecast for 2030?
Based on Monte Carlo simulations, Zions Bancorporation's stock price is projected to be $92.91 in 2030 under a base case scenario. The downside projection is $33.82, while the upside projection reaches $255.27. These are statistical outcomes, not guarantees.
Is Zions Bancorporation stock a buy right now?
Zions Bancorporation is currently rated a 'Hold' by Wall Street, with a consensus score of 50. The stock is trading near its 50-day moving average and shows neutral momentum, suggesting a wait-and-see approach is warranted.
What is Zions Bancorporation's current valuation compared to its peers?
Zions Bancorporation trades at a P/E ratio of 8.81 and a price-to-sales ratio of 2.74, both of which are below the sector medians of 16.50 and 3.80, respectively, indicating a potentially attractive valuation.
What are the key technical indicators for Zions Bancorporation stock?
The stock's RSI is neutral at 55.42, and it is trading below its 50-day and 20-day moving averages, suggesting near-term weakness. However, it remains above the 200-day moving average, which serves as support.
What is the outlook for Zions Bancorporation's earnings and revenue growth?
While Zions has recently beaten EPS estimates, forward growth is projected to moderate, with current year revenue growth at 6.00% and next year at 2.00%. Forward EPS is also expected to decrease year-over-year.
Are insiders buying or selling Zions Bancorporation stock?
Insiders are net sellers of Zions Bancorporation stock, with total sales of $10.2 million significantly exceeding total purchases of $265.6 thousand. This indicates a moderate sell signal from management.
What is the median analyst price target for Zions Bancorporation?
The median analyst price target for Zions Bancorporation is $75.00, suggesting an upside potential of approximately 9.47% from the current stock price of $68.515.

Disclaimer: CleaRank.com is a financial data and analytics provider, not a registered investment advisor, broker-dealer, or financial regulatory body. The stock analysis, trade plans, and AI-generated signals presented for ZION are for educational and informational purposes only and do not constitute financial advice, investment recommendations, or an offer to buy or sell any securities. All trade setups and performance metrics shown are hypothetical, hindsight-based, and simulated. They do not represent actual trades made by CleaRank or its affiliates. Stock prices can be volatile and are subject to market, economic, and company-specific risks. Market data is provided "as-is" and may be delayed by 15 minutes or more. We do not guarantee the accuracy, completeness, or timeliness of any data. You should never invest money you cannot afford to lose. Past performance does not guarantee future results. Consult a qualified financial advisor before making any investment decisions. Analysis generated on September 15, 2026.

Disclaimer:

Engaging in financial markets carries significant risk of total capital loss. Markets are volatile, unpredictable, and past success does not guarantee future results. Never invest funds you cannot afford to lose. CleaRank does not offer financial, investment, or advisory services. We provide no recommendations, endorsements, or guarantees regarding market outcomes. You alone are responsible for your decisions.

Advertiser Disclosure:

At CleaRank, clarity and transparency are more than ideals, they are the core of our operations. CleaRank is a paid SaaS platform: the Pro and Ultra workbench plans are paid subscriptions, while everything else on this site, including our trading calculators, tools and market news, is free to use. In the spirit of full disclosure: some of our free editorial content contains partner links, and we may earn affiliate commissions from them. This never affects what you pay. Please keep in mind that your confidence in our platform is what matters to us most and we are devoted to earning your trust every day through consistent transparency. CleaRank's Editorial team works independently from partner relationships and financial incentives. All material and information made available by CleaRank stem from our unique technology and methodology which are created to prioritize your needs as a trader and deliver actionable insights to help you make clearer decisions.